FDA Expands Pembrolizumab Approval for Endometrial Cancer ...Middle East

News by : (Medscape) -
The FDA expanded the approval of pembrolizumab based on improved PFS in patients with advanced or recurrent endometrial cancer in a randomized phase 3 trial. Medscape Medical News

Hence then, the article about fda expands pembrolizumab approval for endometrial cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Pembrolizumab Approval for Endometrial Cancer )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار